Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 7 (2010), Issue 11 (November)

1. BRAF drives synovial fibroblast transformation in rheumatoid arthritis.
   J Biol Chem, 285(45): 34299-303. [Abstract] [Full-text]
2. A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab.
   Arthritis Rheum, 62(11): 3191-5. [Abstract] [Full-text]
3. The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats.
   Arthritis Rheum, 62(11): 3277-88. [Abstract] [Full-text]
4. The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1.
   Arthritis Rheum, 62(11): 3265-76. [Abstract] [Full-text]
5. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.
   Arthritis Rheum, 62(11): 3259-64. [Abstract] [Full-text]
6. Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate.
   Arthritis Rheum, 62(11): 3154-60. [Abstract] [Full-text]
7. Sustained T cell Rap1 signaling is protective in the collagen-induced arthritis model of rheumatoid arthritis.
   Arthritis Rheum, 62(11): 3289-99. [Abstract] [Full-text]
8. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis.
   Arthritis Rheum, 62(11): 3249-58. [Abstract] [Full-text]
9. No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
   Arthritis Rheum, 62(11): 3145-53. [Abstract] [Full-text]
10. Pathogenic role of CXCR7 in rheumatoid arthritis.
    Arthritis Rheum, 62(11): 3211-20. [Abstract] [Full-text]
11. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis.
    Arthritis Rheum, 62(11): 3183-90. [Abstract] [Full-text]
12. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner.
    Arthritis Rheum, 62(11): 3161-72. [Abstract] [Full-text]
13. Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis.
    Arthritis Rheum, 62(11): 3196-210. [Abstract] [Full-text]
14. Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics.
    Arthritis Rheum, 62(11): 3173-82. [Abstract] [Full-text]
15. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
    Arthritis Rheum, 62(11): 3221-31. [Abstract] [Full-text]
16. The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome.
    Arthritis Rheum, 62(11): 3447-56. [Abstract] [Full-text]
17. A role for lymphotoxin in primary Sjogren's disease.
    J Immunol, 185(10): 6355-63. [Abstract] [Full-text]
18. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
    J Immunol, 185(10): 6373-83. [Abstract] [Full-text]
19. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome.
    Arthritis Care Res (Hoboken), 62(11): 1633-8. [Abstract] [Full-text]
20. Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis.
    Arthritis Care Res (Hoboken), 62(11): 1542-51. [Abstract] [Full-text]
21. Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales.
    Arthritis Care Res (Hoboken), 62(11): 1559-68. [Abstract] [Full-text]
22. Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study.
    Arthritis Care Res (Hoboken), 62(11): 1588-93. [Abstract] [Full-text]
23. The Work Instability Scale for rheumatoid arthritis predicts arthritis-related work transitions within 12 months.
    Arthritis Care Res (Hoboken), 62(11): 1578-87. [Abstract] [Full-text]
24. Validity and responsiveness of the Michigan Hand Questionnaire in patients with rheumatoid arthritis: a multicenter, international study.
    Arthritis Care Res (Hoboken), 62(11): 1569-77. [Abstract] [Full-text]
25. Associations of perceived neighborhood environment on health status outcomes in persons with arthritis.
    Arthritis Care Res (Hoboken), 62(11): 1602-11. [Abstract] [Full-text]
26. Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis.
    Arthritis Care Res (Hoboken), 62(11): 1552-8. [Abstract] [Full-text]
27. Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis.
    Clin Immunol, 137(3): 322-9. [Abstract] [Full-text]
28. Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis.
    Clin Immunol, 137(3): 322-9. [Abstract] [Full-text]
29. B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis.
    Eur J Immunol, 40(11): 3117-27. [Abstract] [Full-text]
30. POSH promotes cell survival in Drosophila and in human RASF cells.
    FEBS Lett, 584(22): 4689-94. [Abstract] [Full-text]
31. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain).
    Scand J Rheumatol, 39(6): 472-9. [Abstract] [Full-text]
32. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
    Scand J Rheumatol, 39(6): 447-53. [Abstract] [Full-text]
33. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study.
    Scand J Rheumatol, 39(6): 454-60. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.